Abstract
SEVERE combined immune deficiency (SCID) represents a hetero-genous group of hereditary diseases. Mutations in the common γ-chain (γc), which is part of several cytokine receptors including those for interleukin (IL)-2, IL-4, IL-7, IL-9 and FL-15, are responsible for X-linked SCID1,2, which is usually associated with a lack of circulating T cells and the presence of B lymphocytes (T- B+ SCID). The gene(s) responsible for autosomal recessive T- B+ SCID is still unknown. The Jak-3 protein kinase3,4 has been found to associate with the γc-chain-containing cytokine receptors4–9. Therefore Jak-3 or other STAT proteins with which it interacts10,11 are candidate genes for autosomal recessive T- B+SCID7. Here we investigate two unrelated T- B+SCID patients (both from consanguineous parents) who have homozygous mutations in the gene for Jak-3. One patient carries a mutation (TyrlOO→Cys) in a conserved tyrosine residue in the JH7 domain of Jak-3 which is absent in more than 150 investigated chromosomes. The other patient carries a homozygous 151-base-pair deletion in the kinase-like domain, leading to a frameshift and premature termination. Both mutations resulted in markedly reduced levels of Jak-3. These findings show that abnormalities in the Jak/STAT signalling pathway can account for SCID in humans.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Noguchi, M. et al. Cell 73, 147–157 (1993).
Schmaistieg, F. C. et al. J. clin. Invest. 95, 1169–1173 (1995).
Kawamura, M. et al. Proc. natn. Acad. Sci. U.S.A. 91, 6374–6378 (1994).
Witthuhn, B. A. et al. Nature 370, 153–157 (1994).
Johnston, J. A. et al. Nature 370, 151–153 (1994).
Boussiotis, V. A. et el. Science 266, 1039–1042 (1994).
Russell, S. M. Science 266, 1042–1045 (1994).
Myazaki, T. et al. Science 266, 1045–1047 (1994).
Musso, T. et al. J. exp. Med. 181, 1425–1431 (1995).
Darnell, J. E., Kerr, I. M. & Start, G. R. Science 264, 1415–1421 (1994).
Ihle, J. N. & Kerr, I. M. Trends Genet. 11, 69–74 (1995).
Cao, X. et al. Immunity 2, 223–238 (1995).
Di Santo, J. P., Muller, W., Guy-Grand, D., Fischer, A. & Rajewsky, K. Proc. natn. Acad. Sci. U.S.A. 93, 377–381 (1995).
Gougeon, M.-L. et al. J. Immun. 145, 2873–2877 (1990).
Wengler, G. S., Allen, R. C., Parolini, O., Smith, H. & Conley, M. E. J. Immun. 150, 700–704 (1993).
Puck, J. M., Nussbaum, R. L. & Conley M. E. J. clin. Invest. 79, 1395–1400 (1987).
Conley, M. E. et al. Proc. natn. Acad. Sci. U.S.A. 85, 3090–3094 (1988).
Chomczynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).
Villa, A. et al. Nature Genet. 9, 414–417 (1995).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Macchi, P., Villa, A., Giliani, S. et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65–68 (1995). https://doi.org/10.1038/377065a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/377065a0
Further reading
-
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
Nature Reviews Rheumatology (2022)
-
A comparative analysis of the intrauterine transcriptome in fertile and subfertile mares using cytobrush sampling
BMC Genomics (2021)
-
Generation of a chemical genetic model for JAK3
Scientific Reports (2021)
-
80 Meilensteine der Rheumatologie aus 80 Jahren – IV: 2000–2020
Zeitschrift für Rheumatologie (2021)
-
JAK Inhibitors: What Is New?
Current Rheumatology Reports (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.